Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol
In Brief: Kung, Vogt, Hartwell Win general Motors Prizes; Fox Chase Hires Four Scientists; Vitetta Honored
Group chairmen Advises 7 Trials For Priority Status
ACCR Considers Foriend Membership, Meeting With ASCO
Evaluation Finds OIG Provides PIs With Flexibility
Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB
DCPC Advisors OK PA On cancer Control In Disadvantaged
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









